Cabaletta Bio, Inc. (CABA)

NASDAQ: CABA · IEX Real-Time Price · USD
1.81
0.32 (21.48%)
At close: May 16, 2022 4:00 PM
1.85
0.04 (2.21%)
After-hours:May 16, 2022 7:33 PM EDT
Market Cap52.45M
Revenue (ttm)n/a
Net Income (ttm)-49.53M
Shares Out28.98M
EPS (ttm)-1.80
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume267,615
Open1.49
Previous Close1.49
Day's Range1.49 - 1.85
52-Week Range1.17 - 14.95
Beta1.35
AnalystsBuy
Price Target15.98 (+782.9%)
Earnings DateMay 16, 2022

About CABA

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune b...

IndustryBiotechnology
IPO DateOct 25, 2019
Employees53
Stock ExchangeNASDAQ
Ticker SymbolCABA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for CABA stock is "Buy." The 12-month stock price forecast is 15.98, which is an increase of 782.87% from the latest price.

Price Target
$15.98
(782.87% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update

– DesCAARTes™ trial clinical and translational data from cohorts A3 and A4 and 28-day safety data from cohort A5 expected to be presented at upcoming scientific meetings in mid-2022 –

4 days ago - GlobeNewsWire

Cabaletta Bio to Present DSG3-CAART Clinical Data and MuSK-CAART Preclinical Data at Upcoming Scientific Meetings in May

PHILADELPHIA, May 02, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients...

2 weeks ago - GlobeNewsWire

CABA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cabaletta Bio, Inc

New York, New York--(Newsfile Corp. - April 29, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cabaletta Bio, Inc....

2 weeks ago - Newsfile Corp

CABA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 29, 2022 in the Class Action Filed on Beh...

New York, New York--(Newsfile Corp. - April 29, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA) alleging...

2 weeks ago - Newsfile Corp

Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Last Few...

New York, New York--(Newsfile Corp. - April 29, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cabaletta Bio, Inc. ("Cabaletta" or "the ...

2 weeks ago - Newsfile Corp

CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming De...

New York, New York--(Newsfile Corp. - April 29, 2022) - Levi & Korsinsky, LLP notifies investors in Cabaletta Bio, Inc. ("Cabaletta" or the "Company") (NASDAQ: CABA) of a class action securities lawsuit...

2 weeks ago - Newsfile Corp

Deadline Today Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Cont...

Los Angeles, California--(Newsfile Corp. - April 29, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...

2 weeks ago - Newsfile Corp

CABA SHAREHOLDER ALERT: Jakubowitz Law Reminds Cabaletta Shareholders of a Lead Plaintiff Deadline of April 29, 2022

NEW YORK, April 29, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA). To receive u...

2 weeks ago - PRNewsWire

Deadline Tomorrow Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to C...

Los Angeles, California--(Newsfile Corp. - April 28, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...

2 weeks ago - Newsfile Corp

FINAL DEADLINE FRIDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secur...

New York, New York--(Newsfile Corp. - April 27, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

2 weeks ago - Newsfile Corp

Deadline Friday Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to ...

Los Angeles, California--(Newsfile Corp. - April 27, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...

2 weeks ago - Newsfile Corp

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cabaletta Bio, Inc. of a Class Action Lawsuit and a Le...

NEW YORK , April 27, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cabaletta Bio, Inc.. Shareholders who purchased shares of CABA during the class period listed ...

2 weeks ago - PRNewsWire

CABA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to...

NEW YORK , April 26, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or traceabl...

2 weeks ago - PRNewsWire

Friday Deadline Notice: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Co...

Los Angeles, California--(Newsfile Corp. - April 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...

2 weeks ago - Newsfile Corp

CABA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 29, 2022 in the Class Action Filed on Beh...

NEW YORK , April 26, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA) alleging that the Comp...

2 weeks ago - PRNewsWire

Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Encourag...

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cabaletta Bio, Inc. ("Cabaletta" or "the Company...

3 weeks ago - Business Wire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Cabaletta Investors of a Lead Plaintiff Deadline of April ...

NEW YORK , April 25, 2022 /PRNewswire/ -- Attention Cabaletta Bio, Inc. ("Cabaletta") (NASDAQ: CABA) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on b...

3 weeks ago - PRNewsWire

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel B...

New York, New York--(Newsfile Corp. - April 23, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

3 weeks ago - Newsfile Corp

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important April ...

New York, New York--(Newsfile Corp. - April 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

3 weeks ago - Newsfile Corp

NATIONALLY RANKED ROSEN LAW FIRM Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Import...

New York, New York--(Newsfile Corp. - April 20, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

3 weeks ago - Newsfile Corp

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cabaletta Bio (CABA) Investors with Significant Losses to Contact...

San Francisco, California--(Newsfile Corp. - April 19, 2022) - Hagens Berman urges Cabaletta Bio, Inc. (NASDAQ: CABA) investors who suffered significant losses to submit your losses now. A securities fr...

3 weeks ago - Newsfile Corp

CABA INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure...

NEW YORK, April 18, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or traceable...

4 weeks ago - PRNewsWire

ROSEN, A RESPECTED AND TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to Secure...

New York, New York--(Newsfile Corp. - April 17, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

4 weeks ago - Newsfile Corp

ROSEN, A LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to Secure Counsel Before I...

New York, New York--(Newsfile Corp. - April 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

1 month ago - Newsfile Corp

CABA SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Loss...

New York, New York--(Newsfile Corp. - April 14, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...

1 month ago - Newsfile Corp